Titelia

Holdings of Virtus Investment Advisers, LLC

415 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 7.7 % of the equity sleeve

Sector breakdown

  • Financials 12.5 %
  • Industrials 11.1 %
  • Technology 9.4 %
  • Health care 8.9 %
  • Consumer discretionary 6.1 %
  • Materials 3.9 %
  • Consumer staples 2.9 %
  • Communication 1.7 %
  • Utilities 1.2 %
  • Real estate 0.8 %
  • Energy 0.4 %
  • Unattributed 41.1 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 98.3 %
  • KY 0.6 %
  • DK 0.3 %
  • GB 0.2 %
  • DE 0.2 %
  • BR 0.2 %
  • LU 0.1 %
  • KR 0.1 %
  • CL 0.1 %
  • TR 0.1 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US398330.6M $98.30 %
2KY31.9M $0.56 %
3DK1876K $0.26 %
4GB5831.2K $0.25 %
5DE1791.4K $0.24 %
6BR3576.2K $0.17 %
7LU1191.9K $0.06 %
8KR1190K $0.06 %
9CL1185.9K $0.06 %
10TR1184.9K $0.05 %

Positions

RankCompanySharesValueWeight
201CAPITAL SOUTHWEST CORP 22,464496.9K $
202First Trust Senior Floating Rate Income Fund II 51,545496.9K $
203BlackRock Debt Strategies Fund 51,502493.9K $
204Eaton Vance Senior Income Trust 98,865493.3K $
205GLADSTONE CAPITAL CORP 28,409492.9K $
206EATON VANCE MUNICIPAL INCOME TRUST 45,894492.4K $
207Sixth Street Specialty Lending Inc 26,629489.4K $
208Ultragenyx Pharmaceutical Inc 23,302488.2K $
209MSC Income Fund Inc 39,921486.2K $
210Corvus Pharmaceuticals Inc 32,579476.6K $
211FS Credit Opportunities Corp 91,877468.6K $
212Rezolute Inc 151,492462.1K $
213Tyra Biosciences Inc 12,049461.5K $
214Barings BDC Inc 55,991460.8K $
215CG oncology Inc 6,660450.7K $
216SLR Investment Corp 31,335448.4K $
217WHITEHORSE FINANCE INC 60,566448.2K $
218Oruka Therapeutics Inc 9,034443.1K $
219Allogene Therapeutics Inc 180,588440.6K $
220Kodiak Sciences Inc 11,451436.5K $
221Arcellx Inc 3,794435.6K $
222Ares Capital Corp 23,885430.4K $
223Nuvation Bio Inc 100,151429.6K $
224Tectonic Therapeutic Inc 13,799426.5K $
225LENZ Therapeutics Inc 46,542425.9K $
226Ares Public Funds 34,335417.5K $
227Blackstone Senior Floating Rat 31,759411.3K $
228Spyre Therapeutics Inc 8,110409.1K $
229CENTESSA PHARMACEUTICALS PLC 10,286408.6K $
230Blackrock Income Trust Inc. 38,229404.1K $
231Morgan Stanley Direct Lending Fund 28,292395K $
232Blackstone Strategic Credit 2027 Term Fund 35,175392.2K $
233BLACKROCK LTD DURATION INCOME TRUST 30,934389.5K $
234Intellia Therapeutics Inc 30,230387.5K $
235ADMA Biologics Inc 42,683384.6K $
236OXFORD SQUARE CAPITAL CORP 213,488377.9K $
237ORIC Pharmaceuticals Inc 29,069368.3K $
238Vir Biotechnology Inc 40,759365.2K $
239Edgewise Therapeutics Inc 11,544363.6K $
240Nuveen Churchill Direct Lending Corp 28,562363.3K $
241Nektar Therapeutics 4,984358.6K $
242Vaxcyte Inc 6,126356K $
243Palvella Therapeutics Inc 2,765344.7K $
244TRIPLEPOINT VENTURE GROWTH BDC CORP 68,513341.9K $
245Relay Therapeutics Inc 33,957337.9K $
246AnaptysBio Inc 6,067336.5K $
247Revolution Medicines Inc 3,454335.9K $
248OFS CAPITAL CORP 92,665329K $
249Praxis Precision Medicines Inc 1,013326.4K $
250Cullinan Therapeutics Inc 22,875325.1K $
251Terns Pharmaceuticals Inc 6,058319.4K $
252Capricor Therapeutics Inc 10,479318.6K $
253Celldex Therapeutics Inc 9,911314.4K $
254Liquidia Corp 8,169308.3K $
255Belite Bio Inc 1,929307.6K $
256CytomX Therapeutics Inc 65,080305.9K $
257Immunome Inc 13,932304.7K $
258Annexon Inc 54,866304K $
259Protagonist Therapeutics Inc 2,860301.4K $
260Apogee Therapeutics Inc 3,538297.8K $
261Celcuity Inc 2,589295.5K $
262Summit Therapeutics Inc 15,519294.2K $
263Bicara Therapeutics Inc 14,755293.5K $
264Denali Therapeutics Inc 15,166291.2K $
265Amylyx Pharmaceuticals Inc 20,815289.3K $
266Rocket Pharmaceuticals Inc 80,438288K $
267Precigen Inc 73,899286K $
268Scholar Rock Holding Corp 5,816285.9K $
269Main Street Capital Corp. 5,380284.9K $
270Omeros Corp 26,865283.7K $
271Cytokinetics Inc 4,303283.6K $
272Rapport Therapeutics Inc 9,007281.8K $
273Compass Therapeutics Inc 52,846279.6K $
274Monte Rosa Therapeutics Inc 16,718275K $
275Stoke Therapeutics Inc 8,418274.1K $
276Arcus Biosciences Inc 12,664273.5K $
277MBX Biosciences Inc 9,131272.6K $
278Zymeworks Inc 10,702268K $
279Ironwood Pharmaceuticals Inc 76,169267.4K $
280Ideaya Biosciences Inc 8,014267K $
281Nuvalent Inc 2,602266.6K $
282Neurogene Inc 13,033262.7K $
283Septerna Inc 10,719257.6K $
284ArriVent Biopharma Inc 11,165257.6K $
285Dyne Therapeutics Inc 14,150256.5K $
286Immunovant Inc 10,320256.3K $
287JADE BIOSCIENCES INC 18,203255.8K $
288Sionna Therapeutics Inc 6,374255.5K $
289Kymera Therapeutics Inc 3,040253.2K $
290Cogent Biosciences Inc 6,476249.3K $
291Janux Therapeutics Inc 17,821247.7K $
292BCP INVESTMENT CORP 32,830246.9K $
293Viking Therapeutics Inc 7,354239.3K $
294Beam Therapeutics Inc 9,966237.5K $
2954D Molecular Therapeutics Inc 25,154234.2K $
296Prime Medicine Inc 66,508231.4K $
297Inhibrx Biosciences Inc 3,425230.3K $
298Arvinas Inc 21,676229.8K $
299AtaiBeckley Inc 63,563225K $
300Compass Pathways plc 40,457223.7K $